Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J J Hoozemans

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
Immunological aspects of alzheimer's disease: therapeutic implicationsJ J Hoozemans, A J Rozemuller, R Veerhuis, et al.
Microscopy Research and Technique|August 31, 2001
Establishment of microglial cell cultures derived from postmortem human adult brain tissue: immunophenotypical and functional characterizationC J de Groot, S Hulshof, J J Hoozemans, et al.
Experimental Gerontology|March 16, 2001
Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E2 secretion by human neuroblastoma cells: implications for Alzheimer's diseaseJ J Hoozemans, R Veerhuis, I Janssen, et al.
Alzheimer Disease and Associated Disorders|June 13, 2000
Neuroinflammation and Alzheimer disease: clinical and therapeutic implicationsP Eikelenboom, A J Rozemuller, J J Hoozemans, et al.
Acta Neuropathologica|February 24, 2001
Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brainJ J Hoozemans, A J Rozemuller, I Janssen, et al.
Acta Neuropathologica|October 1, 1998
Complement C1-inhibitor expression in Alzheimer's diseaseR Veerhuis, I Janssen, J J Hoozemans, et al.
Cellular and Molecular Life Sciences : CMLS|October 23, 2014
BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cellsM Del Campo, C R Oliveira, W Scheper, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
Immunological aspects of alzheimer's disease: therapeutic implicationsJ J Hoozemans, A J Rozemuller, R Veerhuis, et al.
Microscopy Research and Technique|August 31, 2001
Establishment of microglial cell cultures derived from postmortem human adult brain tissue: immunophenotypical and functional characterizationC J de Groot, S Hulshof, J J Hoozemans, et al.
Experimental Gerontology|March 16, 2001
Interleukin-1beta induced cyclooxygenase 2 expression and prostaglandin E2 secretion by human neuroblastoma cells: implications for Alzheimer's diseaseJ J Hoozemans, R Veerhuis, I Janssen, et al.
Alzheimer Disease and Associated Disorders|June 13, 2000
Neuroinflammation and Alzheimer disease: clinical and therapeutic implicationsP Eikelenboom, A J Rozemuller, J J Hoozemans, et al.
Acta Neuropathologica|February 24, 2001
Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brainJ J Hoozemans, A J Rozemuller, I Janssen, et al.
Acta Neuropathologica|October 1, 1998
Complement C1-inhibitor expression in Alzheimer's diseaseR Veerhuis, I Janssen, J J Hoozemans, et al.
Cellular and Molecular Life Sciences : CMLS|October 23, 2014
BRI2 ectodomain affects Aβ42 fibrillation and tau truncation in human neuroblastoma cellsM Del Campo, C R Oliveira, W Scheper, et al.
Pageof 1